When evaluating vaccine efficacy, the conventional measures include reduction of risk of hospitalization and death. The number of patients dying with or without vaccination is often in the public spotlight. However, when evaluating public health interventions or the burden of disease, it is more illustrative to use mortality metrics taking into account also prematurity of the deaths, such as years of life lost (YLL) or years of life saved (YLS) thanks to the vaccination. We develop this approach for evaluation of the difference in YLL and YLS between COVID-19 victims with or without completed vaccination in the autumn pandemic wave (2021, October-December) in Czechia. For the analysis, individual data about all COVID-19 deaths in the country (N = 5797, during the studied period) was used. While 40.6% of the deaths are in cohorts with completed vaccination, this corresponds to 35.1% of years of life lost. The role of vaccination is expressed using YLS and hypothetical numbers of deaths. The registered number of deaths is approximately 3.5 times lower than it would be expected without vaccination. The results illustrate that vaccination is more effective in saving lives than suggested by simplistic comparisons.

Department of Demography and Geodemography Faculty of Sciences Charles University Prague Czechia

Department of Social Geography and Regional Development Faculty of Sciences Charles University Prague Czechia

Zobrazit více v PubMed

ECDC. Latest situation update for the EU/EEA, as of 11 February 2022. (2022). at https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea.

Hulíková Tesárková K, Dzúrová D. The age structure of cases as the key of COVID-19 severity: Longitudinal population-based analysis of European countries during 150 days. Scand. J. Public Health. 2021;50(6):738–747. doi: 10.1177/14034948211042486. PubMed DOI

Murray, C.J.L. & Lopez, A.D. (eds.). Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (The Global Burden of Disease and Injury). (Harvard School of Public Health, 1996).

Mazzuco S, Suhrcke M, Zanotto L. How to measure premature mortality? A proposal combining “relative” and “absolute” approaches. Popul. Health Metrics. 2021;19:41. doi: 10.1186/s12963-021-00267-y. PubMed DOI PMC

Martinez R, Soliz P, Caixeta R, Ordunez P. Reflection on modern methods: Years of life lost due to premature mortality—a versatile and comprehensive measure for monitoring non-communicable disease mortality. Int. J. Epidemiol. 2019;48(4):1367–1376. doi: 10.1093/ije/dyy254. PubMed DOI PMC

Pifarré Arolas H, Acosta E, López-Casasnovas G, Lo A, Nicodemo C, Riffe T, Myrskylä M. Years of life lost to COVID-19 in 81 countries. Sci. Rep. 2021;11:3504. doi: 10.1038/s41598-021-83040-3. PubMed DOI PMC

Mitra AK, Payton M, Kabir N, Whitehead A, Ragland KN, Brown A. Potential years of life lost due to COVID-19 in the United States, Italy, and Germany: An old formula with newer ideas. Int. J. Environ. Res. Public Health. 2020;17(12):4392. doi: 10.3390/ijerph17124392. PubMed DOI PMC

Hanlon P, Chadwick F, Shah A, Wood R, Minton J, McCartney G, Fischbacher C, Mair FS, Husmeier D, Matthiopoulos J, McAllister DA. COVID-19—exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: A modelling study. Wellcome Open Res. 2021;5:75. doi: 10.12688/wellcomeopenres.15849.3. PubMed DOI PMC

Goldstein JR, Cassidy T, Wachter KW. Vaccinating the oldest against COVID-19 saves both the most lives and most years of life. Proc. Natl. Acad. Sci. 2021;118:11. doi: 10.1073/pnas.2026322118. PubMed DOI PMC

Hodcroft, E.B. CoVariants: SARS-CoV-2 mutations and variants of interest. (2021). https://covariants.org.

Komenda, M., Panoška, P., Bulhart, V., Žofka, J., Brauner, T., Hak, J., Jarkovský, J., Mužík, J., Blaha, M., Kubát, J., Klimeš, D., Langhammer, P., Daňková, Š., Májek, O., Bartůňková, M. & Dušek, L. COVID‑19: Přehled aktuální situace v ČR. Onemocnění aktuálně. (Ministry of Health, Czech Republic, 2020). https://onemocneni-aktualne.mzcr.cz/COVID-19. ISSN 2694–9423.

Komenda M, Jarkovský J, Klimeš D, Panoška P, Šanca O, Gregor J, Mužík J, Karolyi M, Májek O, Blaha M, Macková B, Rážová J, Adámková V, Černý V, Blatný J, Dušek L. Sharing datasets of the COVID-19 epidemic in the Czech Republic. PLoS ONE. 2022;17(4):e0267397. doi: 10.1371/journal.pone.0267397. PubMed DOI PMC

Komenda M, Bulhart V, Karolyi M, Jarkovský J, Mužík J, Májek O, Šnajdrová L, Růžičková P, Rážová J, Prymula R, Macková B, Březovský P, Marounek J, Černý V, Dušek L. Complex reporting of the COVID-19 epidemic in the Czech Republic: Use of an interactive web-based app in practice. J. Med. Internet Res. 2020;22(5):e19367. doi: 10.2196/19367. PubMed DOI PMC

WHO. Episode #44 - Delta variant and vaccines, Science conversation. (2021) at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-44---delta-variant-and-vaccines.

Czech Statistical Office. Life Tables for the Czech Republic, Cohesion Regions, and Regions—2018–2019: Complete life tables for the Czech Republic for 2019. (2020) at https://www.czso.cz/csu/czso/life-tables-for-the-czech-republic-cohesion-regions-and-regions-2018-2019.

Šmíd M, Berec L, Přibylová L, Májek O, Pavlík T, Jarkovský J, Weiner J, Barusová T, Trnka J. Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2. J. Infect. Dis. 2022 doi: 10.1093/infdis/jiac161. PubMed DOI PMC

Li H, Wang L, Zhang M, Lu Y, Wang W. Effects of vaccination and non-pharmaceutical interventions and their lag times on the COVID-19 pandemic: Comparison of eight countries. PLoS Negl. Trop. Dis. 2022;16(1):e0010101. doi: 10.1371/journal.pntd.0010101. PubMed DOI PMC

Impacts of COVID-19 pandemic through decomposition of life expectancy according to leading causes and place of death in Czechia